Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 718,747
  • Shares Outstanding, K 50,052
  • Annual Sales, $ 135,080 K
  • Annual Income, $ 8,410 K
  • 60-Month Beta 1.13
  • Price/Sales 5.17
  • Price/Cash Flow 72.62
  • Price/Book 3.01
Trade CARA with:

Options Overview

Details
  • Implied Volatility 58.29%
  • Historical Volatility 24.41%
  • IV Percentile 1%
  • IV Rank 0.94%
  • IV High 143.34% on 09/11/20
  • IV Low 57.48% on 06/11/21
  • Put/Call Vol Ratio 0.86
  • Today's Volume 294
  • Volume Avg (30-Day) 494
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 21,234
  • Open Int (30-Day) 30,983

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.54
  • Number of Estimates 4
  • High Estimate -0.31
  • Low Estimate -0.72
  • Prior Year -0.54
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.96 +8.26%
on 05/17/21
14.41 -2.64%
on 06/15/21
+0.83 (+6.29%)
since 05/14/21
3-Month
11.80 +18.90%
on 05/11/21
29.65 -52.68%
on 04/09/21
-4.89 (-25.85%)
since 03/15/21
52-Week
11.80 +18.90%
on 05/11/21
29.65 -52.68%
on 04/09/21
-1.49 (-9.60%)
since 06/15/20

Most Recent Stories

More News
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned...

SWKH : 17.00 (+0.94%)
CARA : 14.07 (-2.02%)
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

PALM BEACH,  Fla., /PRNewswire/ --  The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing...

RTSL : 0.5600 (+4.67%)
JAZZ : 186.14 (-0.15%)
NTEC : 3.84 (-9.22%)
CARA : 14.07 (-2.02%)
ARNA : 65.96 (-1.23%)
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of 24.19% and -80.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CARA : 14.07 (-2.02%)
Cara: Q1 Earnings Snapshot

STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Monday reported a loss of $23.3 million in its first quarter.

CARA : 14.07 (-2.02%)
Cara Therapeutics (CARA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CARA : 14.07 (-2.02%)
Cara (CARA) Surges 14%: Is This an Indication of Further Gains?

Cara (CARA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

CARA : 14.07 (-2.02%)
Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options

Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.

CARA : 14.07 (-2.02%)
Illumina, Cara Therapeutics rise; Greenbrier, Paychex fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

PAYX : 104.45 (-0.04%)
HES : 89.56 (+1.00%)
BP..LS : 473.100 (+1.67%)
BP : 28.27 (+0.82%)
LUV : 57.02 (-0.45%)
ILMN : 451.21 (-0.21%)
HBM.TO : 7.90 (-6.62%)
CARA : 14.07 (-2.02%)
Thinking about buying stock in Cara Therapeutics, Romeo Power, Ardelyx, LG Display, or Peabody Energy?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CARA, RMO, ARDX, LPL, and BTU.

ARDX : 7.21 (-2.70%)
CARA : 14.07 (-2.02%)
BTU : 8.47 (-3.09%)
LPL : 10.14 (-1.27%)
RMO : 8.56 (-3.06%)
Cara Therapeutics Set to Join S&P SmallCap 600

, /PRNewswire/ -- Cara Therapeutics Inc. (NASD:CARA) will replace MTS Systems Corp. (NASD:MTSC) in the S&P SmallCap 600 effective prior to the opening of trading on . S&P 500 constituent Amphenol Corp....

CARA : 14.07 (-2.02%)
MTSC : 58.49 (-0.02%)
APH : 68.47 (+0.23%)
SPGI : 398.63 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

3rd Resistance Point 14.87
2nd Resistance Point 14.63
1st Resistance Point 14.49
Last Price 14.07
1st Support Level 14.11
2nd Support Level 13.87
3rd Support Level 13.73

See More

52-Week High 29.65
Fibonacci 61.8% 22.83
Fibonacci 50% 20.72
Fibonacci 38.2% 18.62
Last Price 14.07
52-Week Low 11.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar